Xu Tao: AI technology and big data lead the new business format of physical examination and health management in the era of digital intelligence

Reporter Yan Guowen and Cao Xueping report from Beijing

On December 13, the "2023 China Pharmaceutical and Health Industry Summit Forum" hosted by China Business News was held in Beijing.

On the same day, Meinian Health Group (hereinafter referred to as "Meinian Health", stock code: 002044. Xu Tao, President of SZ), was invited to attend the forum, and pointed out in the theme sharing that in the era of digital intelligence, AI technology and big data lead the new format of physical examination and health management, and the four major scientific and technological changes represented by general technology represented by AI large models, biotechnology represented by gene technology, health management represented by wearable devices, and early screening and testing technology with new targets as the core have brought new opportunities for the development of the health industry, and consumption upgrading and quality improvement in the health field are the main trends. Meinian Health continues to be driven by "innovation + technology", and continues to launch specialized, refined, special and new innovative products covering "inspection, medical care, insurance, and management", leading Meinian's new journey with scientific and technological innovation, and upgrading from a leading enterprise in the preventive medical track to a leader in all-round and full-life cycle digital health management.

Digital intelligence empowers new development

According to the "2022-2027 China Health Service Industry Market Panorama Research and Development Prospect Forecast Report" released by the China Research Institute of Puhua Industry Research Institute, the scale of China's health examination market in 2021 will be 189 billion yuan, and it is expected that by 2025, the market size of mainland health examination will exceed 300 billion yuan.

It is understood that Meinian Health currently has more than 600 physical examination centers, and its four major brands fully cover customers at different levels, serving nearly 200 million people since its listing in 2015. Xu Tao introduced that based on the entrance of the traffic platform, Meinian has formed a massive amount of health big data covering social demographics, health history, lifestyle, physical examination, laboratory examination, imaging examination, etc., and has become the largest personal health data center in China.

The reporter learned that Meinian Health actively participates in national key scientific research projects, carries out in-depth scientific research and application of health big data, and focuses on four major directions: serving public health, promoting clinical scientific research, empowering the development of the health industry and improving the quality of health management. For example, Meinian Health took the lead in undertaking the "Key R&D Program of the Ministry of Science and Technology - Construction of Big Data Cloud Platform for Health Examination", which belongs to the key special project of the National Key R&D Program "Active Health and Aging Science and Technology Response", aiming to carry out the in-depth mining and application of health examination big data through the construction of a health examination big data platform, promote the development of the physical examination industry, meet the strategic transformation of "health-centered" and the strategic needs of "healthy aging", and accelerate the "passive health" to "active health".

Xu Tao said that the company adheres to the strategic policy of "medical-oriented, quality-driven, service-supported, and innovation-led", and is continuing to promote the strategic goal of "building a new beautiful year in three years". "In the past two years, the company has pulled through the data middle platform, built an intelligent engine, and the overall digital architecture has taken shape, and is promoting the digitalization of the whole business and the whole process, starting from the order, to the digitization of clinical departments, testing, imaging, general inspection, and customer service."

Meinian Health is building a digital health management platform, and on the medical side, it is building a leading medical operation platform with Bian Que system, LIS system and PACS system, continuously strengthening medical quality management, and realizing electronic and intelligent data analysis from customer appointments, physical examination processes to follow-up services and data analysis, which greatly improves service efficiency and quality, and empowers the digital and intelligent management of the whole process of physical examination.

On the marketing side, the B-end "Xingchen Customer Management System" and the C-end "Meinian Selection" platform precipitate group individual inspection users to create a two-wheel drive mode of group inspection and individual inspection. Among them, since the launch of the "Meinian Selection" distribution mall and the points mall, the business and overall traffic have grown rapidly, and the number of user visits and registrations has shown explosive growth, helping to accelerate the digital marketing process of Meinian Health. "In the next step, we will continue to promote the update and iteration of the digital system, empower business development, accelerate the construction of the membership system, and continuously upgrade the post-examination health management service. Xu Tao said.

Scientific and technological innovation leads a new journey

At present, the development of innovative science and technology is changing with each passing day, among which artificial intelligence technology is showing a trend of continuous integration with the medical and health field, and the industry is more optimistic about the application and implementation of artificial intelligence technology in the field of preventive medicine, especially in the field of health examination. On the one hand, the application of artificial intelligence AI technology can help accurate screening, improve screening accuracy, reduce human error, improve customer experience, and improve customer satisfaction; on the other hand, AI technology can help further improve the efficiency of disease screening and expert reading, reduce costs, and further optimize and empower AI algorithms based on high-quality health big data brought by physical examination traffic, opening up more application scenarios in subdivided fields.

In fact, at present, the application of AI technology in Meinian Health has been very common, covering AI diagnosis of pulmonary nodules, AI diagnosis of stroke, AI diagnosis of brain cognition, AI diagnosis of coronary artery, AI diagnosis of electrocardiogram, AI diagnosis of breast ultrasound, AI quality control of ultrasound, AI diagnosis of fundus, AI assessment of children's bone age, etc., continuing to lead the innovation and development of service formats. Meinian Health has been newly included in the concept of smart medical care and AIGC.

"In the past year, we have released a series of innovative products such as Brain Ray, Lung Tranquility, Meinian Mental Health, and Immune Cell Storage. In the future, we will accelerate the launch of a series of innovative products in vascular health, immunity assessment, diabetes management, female cancer, liver health, etc. Xu Tao said.

Based on high-precision brain magnetic resonance imaging, artificial intelligence image analysis technology and the whole brain standard database of all ages in China's healthy population, it is the first innovative product in China to focus on early screening of stroke and Alzheimer's disease, and is based on high-precision brain magnetic resonance imaging, applying artificial intelligence image analysis technology and the whole brain standard database of all ages in healthy people in China to identify structural abnormalities and functional degeneration in the early stage of brain disease. At the same time, Brain Ruijia pays attention to the post-examination experience of customers, and provides customers with a full range of closed-loop service solutions, including: providing customers with online 1-to-1 report interpretation services, providing professional guidance and consulting services, combining multi-dimensional examination data such as brain function examination, routine physical examination and scale inquiry, comprehensively assessing brain function health, locating high-risk factors, formulating targeted intervention plans, and issuing brain health management reports;

When it comes to AIGC and large models, Xu Tao said that large models require big data, algorithms and computing power, and Meinian Health, as a data "bonanza", will focus on the whole process of physical examination before, during and after the examination, as well as a series of value-added services such as post-examination specialty, genetic testing, chronic disease management, etc., to open up rich business scenarios for large model applications, and at the same time build a new ecology of the medical and health AIGC industry through the "1+1+N" cooperation model.

Xu Tao pointed out that based on the application research of AIGC technology and artificial intelligence data model in the health examination industry, it is necessary to achieve "internal cost reduction and efficiency increase, external product innovation", and internally we are committed to using AI intelligent main examination, AI marketing assistant, AI doctor assistant, and AI health management assistant as enabling tools to continuously improve the operational efficiency of various departments;

As a leading enterprise of preventive medicine in China, Meinian Health has four major brands: "Meinian Health", "Ciming", "Aoya" and "Meizhao", with the mission of "protecting the life and health of Chinese", adhering to the benevolence of doctors, consolidating the construction of internal strength, and meeting the health needs of different groups with multi-level, all-round, precise and personalized health services. In recent years, Meinian Health has continued to build a quality-driven system for the refined operation of medical quality and services, forged innovative product capabilities, and combined with artificial intelligence technology, it has continuously strengthened the research and development of early screening technology for common tumors such as cervical cancer, intestinal cancer, breast cancer, gastric cancer, liver cancer, and lung cancer, continuously improved the connotation of physical examination, and promoted the upgrading of health service formats.

The results of the "2023 CEI Pharmaceutical and Health Industry Selection", which attracted much attention at this forum, were announced, and Meinian Health was awarded the "2023 CEI Pharmaceutical and Health Industry National Trusted Brand Enterprise".